Who Paid My Doc
BelieveIT-201
ClinicalTrials.gov NCT05980598
Research payments
$924,050
Through program year 2025, $924,050 in research payments was reported against BelieveIT-201, across 76 payments, paid by Ascendis Pharma, Inc..
- Paid by
- Ascendis Pharma, Inc.
- ClinicalTrials.gov
- NCT05980598
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $519,694 | 52 |
| 2024 | Research | $334,936 | 22 |
| 2023 | Research | $69,420 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Nashat Gabrail Canton, OH Named on 13 payments
- Ammar Sukari Troy, MI Named on 13 payments
- John Kaczmar Charlotte, NC Named on 8 payments
- Timothy Panella Nashville, TN Named on 5 payments
- Michael Jelinek Chicago, IL Named on 4 payments
- Lukasz Czerwonka Stony Brook, NY Named on 4 payments
- Daniel Vinh Indianapolis, IN Named on 3 payments
- Katharine Price Rochester, MN Named on 3 payments
- Neil Gross Houston, TX Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.